A clinical trial to evaluate efficacy of Saptaparna (Alstonia Scholaris Linn.) Twak Churna in Vicharchika (Eczema)

  • Dr. Keyurgiri R. Gosai Final year M.D. Scholar, Department of Dravya Guna, Parul Institute of Ayurveda, Vadodara, Gujarat, India.
  • Rekha Parmar Associate Professor, Department of Dravyaguna, Parul Institute of Ayurveda, Vadodara, Gujarat, India.
DOI: https://doi.org/10.21760/jaims.v2i02.141
Keywords: Kushtha, Vicharchika, Eczema, Saptaparna, Alstonia scholaris Linn

Abstract

Skin diseases are very commonly seen in today's era due to irregular food habits and awkward lifestyle. Each and every person is being suffered from the same irregular lifestyle. Due to the same there is a need to discover the drug which can be administered in the skin without any side effects. There are many references found regarding treatment of Vicharchika (Eczema) in Ayurvedic texts but we need the drug which can act like a magical tool in the management of Vicharchika (Eczema). In Bhavaprakash Nighantu, efficacy of Saptaparna (Alstonia scholaris Linn.) has been mentioned in Kushtha. So, this clinical trial had been carried out to evaluate effect of Saptaparna Twak Churna in management of Vicharchika (Eczema).

Downloads

Download data is not yet available.

References

Charak Samhita of Agnivesh Revised by Charak and Dridhabala Hindi commentary by Vidyotini, Reprint ed., Chaukhambha Publications, Varanasi, Sutra sthana, chapter-4.2008

K C Chunekar. Bhavprakash Nighantu of Shri Bhavmishra. Reprint ed., Chaukhambha Publication, Varanasi, Vatadi Varga, 2009;p.546
CITATION
DOI: 10.21760/jaims.v2i02.141
Published: 2017-04-30
How to Cite
Dr. Keyurgiri R. Gosai, & Rekha Parmar. (2017). A clinical trial to evaluate efficacy of Saptaparna (Alstonia Scholaris Linn.) Twak Churna in Vicharchika (Eczema). Journal of Ayurveda and Integrated Medical Sciences, 2(02), 54-57. https://doi.org/10.21760/jaims.v2i02.141
Issue
Vol. 2 No. 02 (2017): MAR-APR
Section
Original Article

Journal of Ayurveda and Integrated Medical Sciences (JAIMS) retains the copyright of the contents of this journal but grant the readers the right to use the contents with terms and conditions under a creative common attribution licenses 4 of Attribution, Share Alike and Non-commercial type (CC BY-NC-SA) that allows copy, distribute, display, and perform the work and make derivative works based on it only for non-commercial purposes.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.